FABP7 and non-small cell lung carcinoma: To experimentally validate its metastasis-facilitating ability, we constructed two NSCLC cell lines (A549 and H1975) with stable overexpression or knockdown of FABP7, followed by examination of expressional efficiencies (Figure 2C).